Telomere damage enhances immunogenicity of neuroblastoma and accelerates response to anti-PD-L1 treatment
{{output}}
Telomerase is active in the majority of high-risk neuroblastomas, a pediatric tumor associated with poor patient outcomes. In other cancer types, resistance to immune checkpoint blockade was overcome by induction of telomere dysfunction using the telomerase su... ...
